sevoflurane has been researched along with Carcinoma, Epidermoid in 6 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the effect of sevoflurane on head and neck squamous cell carcinoma (HNSCC) remains unclear." | 1.48 | Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro. ( Chen, Z; Hu, R; Jiang, H; Jiang, J; Lu, Y; Yan, J; Yang, Y, 2018) |
| "The effect of sevoflurane on tongue squamous cell carcinoma (TSCC) cell has not been investigated." | 1.42 | Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcinoma cell by upregulating the DNA methylation states of the promoter region. ( Hu, R; Huang, Y; Jiang, H; Lu, Y; Sun, Y; Wang, J; Yan, J; Yang, Y; Zhang, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, D | 1 |
| Wan, L | 1 |
| Gong, H | 1 |
| Chen, S | 1 |
| Kong, Y | 1 |
| Xiao, B | 1 |
| Rezniczek, GA | 1 |
| Hecken, JM | 1 |
| Rehman, S | 1 |
| Dogan, A | 1 |
| Tempfer, CB | 1 |
| Hilal, Z | 1 |
| Zarrouki, Y | 1 |
| Makoudi, M | 1 |
| Ziadi, A | 1 |
| Elamrani, D | 1 |
| Ettalbi, S | 1 |
| Samkaoui, MA | 1 |
| Yang, Y | 2 |
| Hu, R | 2 |
| Yan, J | 2 |
| Chen, Z | 1 |
| Lu, Y | 2 |
| Jiang, J | 1 |
| Jiang, H | 2 |
| Wang, J | 1 |
| Sun, Y | 1 |
| Huang, Y | 1 |
| Zhang, Y | 1 |
| Liu, S | 1 |
| Gu, X | 1 |
| Zhu, L | 1 |
| Wu, G | 1 |
| Zhou, H | 1 |
| Song, Y | 1 |
| Wu, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Large Loop Excision of the Transformation Zone (LLETZ) With Versus Without Intraoperative Application of Lugol's Iodine in Women With Cervical Dysplasia: a Prospective Randomized Trial[NCT05132114] | 216 participants (Anticipated) | Interventional | 2022-01-17 | Recruiting | |||
| Large Loop Excision of the Transformatione Zone Under General Versus Local Anesthesia: a Randomized Trial.[NCT03494686] | 229 participants (Actual) | Interventional | 2018-04-03 | Completed | |||
| Sevoflurane Sedation: A Potentially Promising Immunomodulation in Patients With Septic Shock[NCT03643367] | Phase 2 | 153 participants (Anticipated) | Interventional | 2025-01-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for sevoflurane and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial.
Topics: Adenocarcinoma in Situ; Adult; Anesthesia, General; Anesthesia, Local; Anesthetics, Inhalation; Anes | 2020 |
Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Anesthetics, Inhalation; Anesthetics, Intravenous; Carcinoma, Squamous Cell; CD4-CD8 | 2016 |
4 other studies available for sevoflurane and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Sevoflurane promotes the apoptosis of laryngeal squamous cell carcinoma in-vitro and inhibits its malignant progression via miR-26a/FOXO1 axis.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Forkhead Box Protein O1; Hum | 2021 |
Anesthesia for patients with xeroderma pigmentosum: A twelve consecutive patients case series.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Androstanols; Anemia; Anesthesia; | 2017 |
Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Gene Expres | 2018 |
Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcinoma cell by upregulating the DNA methylation states of the promoter region.
Topics: Azacitidine; Base Sequence; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Movement; | 2015 |